Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2023 08:00 ET | Source: MediWound Ltd.

MediWound to Report First Quarter 2023 Financial Results

YAVNE, Israel, May 12, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced that the Company will...
May 09, 2023 07:30 ET | Source: MediWound Ltd.

MediWound Announces an Additional $10 Million Award from BARDA

YAVNE, Israel, May 09, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair,...
April 26, 2023 08:00 ET | Source: MediWound Ltd.

MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023

Data to be highlighted in oral and poster presentations YAVNE, Israel, April 26, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on...
March 16, 2023 07:10 ET | Source: MediWound Ltd.

MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update

2022 total revenues of $26.5 million FDA approval of NexoBrid® in December 2022; U.S. commercial availability expected in the second quarter of 2023 EscharEx® Phase III protocol design is under...
March 16, 2023 07:00 ET | Source: MediWound Ltd.

MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer

YAVNE, Israel, March 16, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company specializing in next-generation biotherapeutic solutions for tissue...
March 06, 2023 07:00 ET | Source: MediWound Ltd.

MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth

Appoints Barry Wolfenson, as Executive Vice President of Strategy and Corporate Development Appoints Alicia Torrenova, as Vice President of European Operations Both bring extensive leadership...
March 02, 2023 08:47 ET | Source: MediWound Ltd.

MediWound to Report Fourth Quarter and Year-End 2022 Financial Results

YAVNE, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair...
February 23, 2023 08:00 ET | Source: MediWound Ltd.

MediWound to Present Corporate Highlights at Upcoming Investor Conferences

YAVNE, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for...
February 07, 2023 16:01 ET | Source: MediWound Ltd.

MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares

YAVNE, Israel, Feb. 07, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and...
February 03, 2023 10:30 ET | Source: MediWound Ltd.

MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market

YAVNE, Israel, Feb. 03, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for...